Deciphering and predicting the evolution of cancer cell populations

Project description

Novel sequencing technology for cancer evolution analysis

Fields of science

• natural sciences › biological sciences › genetics › DNA
• natural sciences › biological sciences › evolutionary biology
• medical and health sciences › basic medicine › pharmacology and pharmacy › drug resistance
• medical and health sciences › clinical medicine › oncology
• medical and health sciences › basic medicine › immunology › immunotherapy

Programme(s)

• H2020-EU.1.1. - EXCELLENT SCIENCE - European Research Council (ERC) Main Programme

Topic(s)

• ERC-2018-COG - ERC Consolidator Grant

Call for proposal

ERC-2018-COG

See other projects for this call

Funding Scheme

ERC-COG - Consolidator Grant

Host institution

QUEEN MARY UNIVERSITY OF LONDON

Net EU contribution

€ 1 250 303,75

Address

327 Mile End Road
E1 4NS London
United Kingdom

Region

London › Inner London — East › Tower Hamlets

Activity type

Higher or Secondary Education Establishments

Links

Other funding

€ 0,00

Beneficiaries (2)

QUEEN MARY UNIVERSITY OF LONDON

United Kingdom

Net EU contribution

€ 1 250 303,75

Address

327 Mile End Road
E1 4NS London

Region

London › Inner London — East › Tower Hamlets

Activity type

Higher or Secondary Education Establishments

Links

Other funding

€ 0,00

THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL

United Kingdom

Net EU contribution

€ 749 696,25

Address

Old Brompton Road 123
SW7 3RP London

Activity type

Higher or Secondary Education Establishments

Links

Other funding

€ 0,00